Internal Medicine, Nephrology · Orange Park, FL
NPI
1316969595
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
1563 Kingsley Avenue, Suite 106
Orange Park, FL, 32073
Phone (904) 389-5333
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
2,048 services
Medicare patients, 2024
610
Average age 76
Drug cost, 2024
$86K
695 prescriptions
Company payments, 2025
$645
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bachar Alkhalil was code 99232 (hospital e&m - subsequent), 589 times for 209 patients. In total Bachar Alkhalil billed 2,048 services in 14 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 589 | 209 | $61.10 | $36K |
| 99214 Office E&M - Established | Office | 449 | 266 | $96.04 | $43K |
| 99233 Hospital E&M - Subsequent | Facility | 298 | 137 | $91.82 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 153 | 127 | $11.67 | $1,786 |
| 99215 Office E&M - Established | Office | 141 | 88 | $132.45 | $19K |
| 99223 Hospital E&M - Initial | Facility | 103 | 95 | $134.67 | $14K |
| 90960 ESRD Related Services (not dialysis) | Office | 95 | 24 | $286.64 | $27K |
| 99204 Office E&M - New | Office | 80 | 80 | $127.15 | $10K |
| 99222 Hospital E&M - Initial | Facility | 56 | 54 | $101.81 | $5,702 |
| 99205 Office E&M - New | Office | 30 | 30 | $171.95 | $5,159 |
| 90961 ESRD Related Services (not dialysis) | Office | 24 | 14 | $237.42 | $5,698 |
By year: 2022 $195K for 1,921 services; 2023 $162K for 1,631 services; 2024 $199K for 2,048 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bachar Alkhalil prescribed most often to Medicare patients was Amlodipine Besylate, with 70 prescriptions and refills. In total Bachar Alkhalil wrote 695 Medicare prescriptions that cost $86K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 70 | 187 | 29 | $417 |
| Carvedilol Generic | 52 | 110 | 13 | $254 |
| Calcitriol Generic | 50 | 95 | 13 | $698 |
| Hydralazine Hcl Generic | 48 | 120 | 15 | $688 |
| Losartan Potassium Generic | 38 | 109 | 17 | $283 |
| Doxazosin Mesylate Generic | 31 | 67 | 12 | $312 |
| Bumetanide Generic | 24 | 56 | Under 11 | $566 |
| Farxiga Dapagliflozin Propanediol | 23 | 25 | Under 11 | $14K |
| Torsemide Generic | 19 | 37 | Under 11 | $333 |
| Veltassa Patiromer Calcium Sorbitex | 17 | 19 | Under 11 | $17K |
| Spironolactone Generic | 16 | 44 | Under 11 | $162 |
| Lisinopril Generic | 16 | 34 | Under 11 | $88.18 |
| Olmesartan Medoxomil Generic | 16 | 34 | Under 11 | $162 |
| Famotidine Generic | 15 | 37 | Under 11 | $31.39 |
| Metoprolol Succinate Generic | 14 | 20 | Under 11 | $63.82 |
Brand drugs: 70 claims; generic drugs: 625 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bachar Alkhalil $645 ($645 in general payments such as food, travel and fees) from 15 companies. The largest payer was Travere Therapeutics, Inc. with $86.98.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 5 | $86.98 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $69.64 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $67.53 |
| Calliditas Therapeutics US Inc. | 3 | $64.88 |
| Shield Therapeutics Inc STX.L | 1 | $51.62 |
| Vifor Pharma, Inc. | 2 | $41.67 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $40.36 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.32 |
| CorMedix Inc. CRMD | 2 | $34.51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.